Le Lézard
Classified in: Health
Subjects: SVY, CPG

Organ donation and transplantation: CLOSE TO 80% OF QUEBECERS WANT SPECIFIC AND COMPREHENSIVE LEGISLATION


MONTREAL, April 18, 2024 /CNW/ - According to a Léger survey conducted for Transplant Québec, more than three in four people favour the adoption, by Québec, of specific and comprehensive legislation governing organ donation and transplantation. At a time when the National Assembly is undertaking a reflection on the means of facilitating organ donation and transplantation across the province, Transplant Québec wanted to learn more about where Quebecers stand on the issue, in conjunction with the start of National Organ and Tissue Donation Awareness Week, which runs from April 21 to 27, 2024.

"Reflecting the concrete needs experienced in the field, we see that there is strong public support for a much-needed organ donation reform, notably through the adoption of specific and comprehensive legislation on the matter. These findings give elected officials a mandate to continue their work and expedite the process of adopting legislation so that more lives can be saved," said Martine Bouchard, Executive Director of Transplant Québec.

The need for action on several fronts to improve Québec's performance
In addition to demonstrating significant public support for the adoption of a legislative framework, the survey findings indicate that respondents hold a favourable view of a range of measures being implemented to improve Québec's performance.
Among the priorities cited by respondents, three stand out:

Moreover, respondents are of the opinion that the following additional elements must be taken into consideration: School-based training activities should be offered to promote awareness of organ donation among students; an organization responsible and accountable for organ donation must be identified; and organ donation training must be made mandatory for health professionals.

"These data attest to the fact that the organ donation and transplantation process is highly complex, as they show that the public is in favour of a legislative bill containing multiple concrete measures, above and beyond the issue of consent. Drawing on its unique and highly specialized expertise, Transplant Québec has the know-how and the tools to deploy such a reform," added the organization's executive director.

Concrete recommendations for improving performance
The survey results directly reflect the 12 recommendations that Transplant Québec tabled before the parliamentary commission held on January 31, 2024. Based on the scientific literature, along with best global practices and opinions from recognized experts, these recommendations revolve around four areas of action: The organization of donation, including its structure, processes and levers, training of health professionals, respect for last wills, and consent.

"Transplant Québec wishes to actively contribute to the work already undertaken by our elected officials. We must contribute, on behalf of all patients awaiting an organ transplant, and for all deceased donors and their families. We have a duty to do better because there is definitely room for improvement," said Martine Bouchard, the Executive Director of Transplant Québec.

The Léger survey was conducted with 1,000 Quebecers on behalf of Transplant Québec from April 11 to 14, 2024.

About Transplant Québec
The Minister of Health and Social Services has mandated Transplant Québec to save lives and improve the health of persons in need of a transplant by coordinating the organ donation process, ensuring the equitable allocation of organs, supporting best clinical practices through consensus building and the mobilization of its partners, and promoting organ donation in society. Transplant Québec strives to ensure that as many Quebecers as possible who are waiting on an organ can receive a transplant in a timely manner.

SOURCE Transplant Québec


These press releases may also interest you

at 02:05
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...

at 02:00
With Denmark as the centre of gravity, the ambition is to invest in, support and advance some of the world's most promising quantum technology companies with applications in the life sciences. The quantum industry, which develops novel technologies...

at 01:40
In a significant move to meet the growing demand for health management solutions, the 135th China Import and Export Fair ("Canton Fair" or "the Fair") has brought together top-tier companies from the Medicines, Health Products and Medical Devices...

at 00:05
As May marks Preeclampsia Awareness Month, leading maternal health experts, preeclampsia survivors and industry leaders have come together on a new campaign, "Preeclampsia Prevention is Possible." The campaign elevates awareness of a major paradigm...

30 avr 2024
The report titled "Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization &...

30 avr 2024
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online. Prof. Yuankai Shi, chief physician of...



News published on and distributed by: